Literature DB >> 24726876

Recruitment of phosphatase PP2A by RACK1 adaptor protein deactivates transcription factor IRF3 and limits type I interferon signaling.

Lingyun Long1, Yuezhen Deng1, Fan Yao1, Dongxian Guan1, Yuanyuan Feng1, Hao Jiang1, Xiaobin Li1, Pingting Hu1, Xincheng Lu1, Hui Wang1, Jingjing Li1, Xiang Gao2, Dong Xie3.   

Abstract

The transcription factor IRF3 is a central regulator of type I interferon (IFN) signaling. The mechanisms underlying deactivation of IRF3 are poorly understood although many studies suggest that IRF3 activity is terminated through degradation after viral infection. Here we report that IRF3 is deactivated via dephosphorylation mediated by the serine and threonine phosphatase PP2A and its adaptor protein RACK1. The PP2A-RACK1 complex negatively regulated the IRF3 pathway after LPS or poly(I:C) stimulation or Sendai virus (SeV) infection. After challenge with LPS, poly(I:C), or low-titer SeV, activated IRF3 was dephosphorylated and returned to resting state without being degraded, although high-titer SeV infection triggered the degradation of IRF3. Furthermore, PP2A-deficient macrophages showed enhanced type I IFN signaling upon LPS, poly(I:C), and SeV challenge and protected mice from lethal vesicular stomatitis virus infection. Therefore, dephosphorylation of IRF3 is a deactivation mechanism that contributes to termination of IRF3-type I IFN signaling.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24726876     DOI: 10.1016/j.immuni.2014.01.015

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  51 in total

Review 1.  Mechanisms and pathways of innate immune activation and regulation in health and cancer.

Authors:  Jun Cui; Yongjun Chen; Helen Y Wang; Rong-Fu Wang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Lnc(ing) interferon production and action.

Authors:  Ganes C Sen; Bryan R G Williams
Journal:  Cell Res       Date:  2019-09       Impact factor: 25.617

3.  Elevated sodium chloride drives type I interferon signaling in macrophages and increases antiviral resistance.

Authors:  Wu-Chang Zhang; Lin-Juan Du; Xiao-Jun Zheng; Xiao-Qing Chen; Chaoji Shi; Bo-Yan Chen; Xue-Nan Sun; Chao Li; Yu-Yao Zhang; Yan Liu; Hui Xiao; Qibin Leng; Xinquan Jiang; Zhiyuan Zhang; Shuyang Sun; Sheng-Zhong Duan
Journal:  J Biol Chem       Date:  2017-12-04       Impact factor: 5.157

4.  A conserved miRNA-183 cluster regulates the innate antiviral response.

Authors:  Ragunath Singaravelu; Nadine Ahmed; Curtis Quan; Prashanth Srinivasan; Christopher J Ablenas; Dominic G Roy; John Paul Pezacki
Journal:  J Biol Chem       Date:  2019-11-06       Impact factor: 5.157

5.  The TEL-AML1 fusion protein of acute lymphoblastic leukemia modulates IRF3 activity during early B-cell differentiation.

Authors:  A de Laurentiis; J Hiscott; M Alcalay
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

6.  Inhibition of protein phosphatase-2A with LB-100 enhances antitumor immunity against glioblastoma.

Authors:  Dominic Maggio; Winson S Ho; Rebecca Breese; Stuart Walbridge; Herui Wang; Jing Cui; John D Heiss; Mark R Gilbert; John S Kovach; Rongze O Lu; Zhengping Zhuang
Journal:  J Neurooncol       Date:  2020-04-27       Impact factor: 4.130

7.  Fine-Tuning of the RIG-I-Like Receptor/Interferon Regulatory Factor 3-Dependent Antiviral Innate Immune Response by the Glycogen Synthase Kinase 3/β-Catenin Pathway.

Authors:  Kashif Aziz Khan; Florence Dô; Alexandre Marineau; Priscilla Doyon; Jean-François Clément; James R Woodgett; Bradley W Doble; Marc J Servant
Journal:  Mol Cell Biol       Date:  2015-06-22       Impact factor: 4.272

8.  Cellular FLIP long isoform (cFLIPL)-IKKα interactions inhibit IRF7 activation, representing a new cellular strategy to inhibit IFNα expression.

Authors:  Lauren T Gates-Tanzer; Joanna L Shisler
Journal:  J Biol Chem       Date:  2017-12-08       Impact factor: 5.157

9.  LncRNA Malat1 inhibition of TDP43 cleavage suppresses IRF3-initiated antiviral innate immunity.

Authors:  Wei Liu; Ziqiao Wang; Lun Liu; Zongheng Yang; Shuo Liu; Zhongfei Ma; Yin Liu; Yuanwu Ma; Lianfeng Zhang; Xuan Zhang; Minghong Jiang; Xuetao Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-09       Impact factor: 11.205

10.  cFLIPL Interrupts IRF3-CBP-DNA Interactions To Inhibit IRF3-Driven Transcription.

Authors:  Lauren T Gates; Joanna L Shisler
Journal:  J Immunol       Date:  2016-06-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.